论文部分内容阅读
目的：评价克淋通胶囊治疗急性前列腺炎（湿热瘀阻证）的临床疗效和安全性。方法入选急性前列腺炎患者112例，随机分为试验组（ n＝84）和对照组（n＝28）。试验组口服克淋通胶囊（每粒0.4 g），每次3粒，每日3次；对照组口服热淋清胶囊（每粒0.3 g），每次4粒，每日3次。疗程均为7～14 d。试验组和对照组患者分别于治疗前后进行中医证候评分、血尿常规分析、前列腺液常规、前列腺B超检查和不良反应评价。结果试验组、对照组完成试验病例分别为81例和25例。试验组综合疗效和中医症候疗效总有效率均显著高于对照组，差异有统计学意义（P＜0.05）。试验组不良事件发生率低于对照组，差异有统计学意义（ P＜0.05）。结论克淋通胶囊在治疗急性前列腺炎（湿热瘀阻证）中具有良好的效果，且不良反应少。“,”Objective To evaluate the curative effect and safety of the Kelintong capsules on acute prostatitis.Methods One hundred and twelve patients with acute prostatitis were randomly divided into test group (84 cases) and control group (28 cases).Patients in test group were treated with kelintong capsule ( 0.4 g per pill for 3 pills, three times each day ) , and patients in control group were treated with relin-qing capsule ( 0.3 g per pill for 4 pills, three times each day ).The treatment lasted for 7 to 14 days.The data of traditional Chinese medi-cine( TCM) syndrome score, urine routine examination, prostate fluid routine, prostate B -ultrasound and adverse reactions in both groups were observed before and after treatment.Results A total of 81 in the test group and 25 in the control group finished the study.The data of to-tal effective rate for comprehensive curative effect and TCM symptoms were significantly higher in test group than that of control group, respec-tively ( P<0.05 ).The incidences of adverse reactions in test group were lower than those in control group(P<0.05).Conclusion The Keling-tong capsule is effective for patients with acute prostatitis, with less adverse reactions.